Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sharps Technology Inc WT (STSSW)

Sharps Technology Inc WT (STSSW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END

STSSW : 0.0700 (-15.87%)
STSS : 0.2896 (-1.83%)
BDX : 237.30 (+1.94%)
CAH : 98.35 (+1.49%)
NVO : 126.73 (-0.88%)
TRUMY : 17.7200 (+1.20%)
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility

FDA/CE-Mark facility to produce our full range of world-class specialty safety syringes...

STSS : 0.2896 (-1.83%)
STSSW : 0.0700 (-15.87%)
Sharps Technology Announces Letter to Shareholders

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company...

STSS : 0.2896 (-1.83%)
STSSW : 0.0700 (-15.87%)
Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company...

STSS : 0.2896 (-1.83%)
STSSW : 0.0700 (-15.87%)

Barchart Exclusives

Up 128% YTD, Should You Still Invest in Nvidia Stock?
For investors looking to capitalize on a leader in the AI revolution, Nvidia remains a compelling opportunity with a promising outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar